| Drug General Information |
| Drug ID |
D0O0ZU
|
| Former ID |
DNC002741
|
| Drug Name |
Hexane-1,6-Diol
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C6H14O2
|
| Canonical SMILES |
C(CCCO)CCO
|
| InChI |
1S/C6H14O2/c7-5-3-1-2-4-6-8/h7-8H,1-6H2
|
| InChIKey |
XXMIOPMDWAUFGU-UHFFFAOYSA-N
|
| CAS Number |
CAS 629-11-8
|
| PubChem Compound ID |
|
| PubChem Substance ID |
67411, 584241, 822591, 822814, 823258, 823600, 827618, 829181, 831266, 831270, 3133403, 6436504, 6793753, 7888133, 8023367, 8159244, 10530956, 12075532, 15170579, 17404149, 17422752, 22389447, 22394887, 22394895, 22394900, 22394905, 24854405, 24889114, 24895435, 35231290, 46508366, 48417662, 49834179, 49976121, 56368637, 56394675, 57244425, 57269297, 57327565, 57653317, 58874592, 78535854, 81054269, 81064825, 81067225, 85085512, 85149314, 85175293, 85786872, 85786910
|
| Target and Pathway |
| Target(s) |
Phospholipase A2 |
Target Info |
Inhibitor |
[1]
|
|---|
| Glucocorticoid receptor |
Target Info |
Inhibitor |
[1]
|
|
BioCyc Pathway
|
Phospholipases
|
|
KEGG Pathway
|
Glycerophospholipid metabolism
|
|
Ether lipid metabolism
|
|
Arachidonic acid metabolism
|
|
Linoleic acid metabolism
|
|
alpha-Linolenic acid metabolism
|
|
Metabolic pathways
|
|
Ras signaling pathway
|
|
Vascular smooth muscle contraction
|
|
Pancreatic secretion
|
|
Fat digestion and absorptionhsa04080:Neuroactive ligand-receptor interaction
|
|
NetPath Pathway
|
IL2 Signaling Pathway
|
|
TCR Signaling Pathway
|
|
Pathway Interaction Database
|
Fc-epsilon receptor I signaling in mast cellssmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling
|
|
Signaling events mediated by HDAC Class II
|
|
FOXA2 and FOXA3 transcription factor networks
|
|
Glucocorticoid receptor regulatory network
|
|
Regulation of Androgen receptor activity
|
|
AP-1 transcription factor network
|
|
Reactome
|
Acyl chain remodelling of PC
|
|
Acyl chain remodelling of PE
|
|
Acyl chain remodelling of PIR-HSA-1368108:BMAL1:CLOCK,NPAS2 activates circadian gene expression
|
|
WikiPathways
|
Glycerophospholipid biosynthesisWP734:Serotonin Receptor 4/6/7 and NR3C Signaling
|
|
SIDS Susceptibility Pathways
|
|
Nuclear Receptors Meta-Pathway
|
|
Endoderm Differentiation
|
|
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
|
|
Adipogenesis
|
|
Circadian Clock
|
|
Nuclear Receptors
|
| References |
| REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
|---|
